Tuhura Biosciences展示数据显示,Delta阿片受体(Dor)作为克服对免疫检查点抑制剂获得性耐药的新靶点,亮相第57届ASH年会暨博览会。
Tuhura Biosciences展示数据显示,Delta阿片受体(Dor)作为克服对免疫检查点抑制剂获得性耐药的新靶点,亮相第57届ASH年会暨博览会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.